Cahill Wealth Management’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,475
Closed -$29K 46
2023
Q3
$29K Sell
10,475
-63,384
-86% -$194K 0.02% 47
2023
Q2
$233K Buy
73,859
+8,309
+13% +$30K 0.16% 43
2023
Q1
$342K Buy
65,550
+8,485
+15% +$60.9K 0.25% 39
2022
Q4
$404K Buy
57,065
+33,715
+144% +$304K 0.29% 39
2022
Q3
$292K Buy
+23,350
New +$279K 0.26% 37

Other funds holding SRTS

Cahill Wealth Management's SRTS Position: Q4 2023 in Review

Cahill Wealth Management sold out of Sensus Healthcare (SRTS) in Q4 2023, closing a stake of 10,475 shares — an estimated $29K sold.

Cahill Wealth Management first reported a position in SRTS in Q3 2022 and held it in 5 quarters. The position peaked at $404K in Q4 2022. 41 funds tracked by Wall St. Rank hold SRTS as of Q4 2023.

  • Cahill Wealth Management reported no remaining Sensus Healthcare position as of Q4 2023 after selling out during the quarter.
  • Cahill Wealth Management sold 10,475 Sensus Healthcare shares in Q4 2023, an estimated $29K.
  • Cahill Wealth Management first reported a position in Sensus Healthcare in Q3 2022 and held it in 5 quarters.
  • Cahill Wealth Management's Sensus Healthcare position peaked at $404K in Q4 2022.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2023.

Based on Cahill Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.